Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/side-effects-of-medical-cancer-therapy/descriptif_3853364
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3853364

Side Effects of Medical Cancer Therapy (2nd Ed., Softcover reprint of the original 2nd ed. 2018) Prevention and Treatment

Langue : Anglais

Coordonnateurs : Dicato Mario A., Van Cutsem Eric

Couverture de l’ouvrage Side Effects of Medical Cancer Therapy
This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest  progress in drug discovery such as targeted therapies for each cancer type. From issues such as preservation of fertility to antiemetic therapy the book provides a very comprehensive overview of the field. The book includes a new chapter on immuno-oncology drugs. 

Organised by organ system, it lists the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects are  priority so as to alert the reader to their importance.

Designed for quick reference in the clinical setting this book is primarily aimed at established medical oncologists but will also appeal to junior doctors, trainees, pharmacists and nurses.

Drug Interactions and Pharmacogenetics

François Lokiec

Breast Cancer

Matteo Lambertini, Philippe Aftimos, Andrea Gombos, Ahmad Awada, and Martine Piccart

Lung Cancer

Solange Peters and Stefan Zimmermann

Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment

Julie Bogaert, Pieter-Jan Cuyle, and Eric VanCutsem

Gynecologic Cancer

Sevilay Altintas and Dirk L. A. L. Schrijvers

Side Effects of Medical Cancer Therapy in Genitourinary Malignancies

Bertrand F. Tombal, Christine Remacle, and Monique Kasa Vubu

Central Nervous System

Patrizia Farina, Florian Scotté, Chiara Villa, Bertrand Baussart, and Anna Luisa Di Stefano

Myeloid Malignancies

Laurent Plawny

Lymphoma

Sigrid Cherrier-De Wilde

Multiple Myeloma

Mario A. Dicato

Dermatologic Side Effects of Systemic Targeted Anticancer Therapy

Caroline Robert, Christina Mateus, and Alexander M. M. Eggermont

Immune Checkpoint Inhibition

Sarah Sammons, Megan McNamara, April K. S. Salama, and Jeffrey Crawford

Preservation of Fertility in the Cancer Patient

Duhem Caroline and Fernand Ries

Cardiotoxicity

I. Brana, E. Zamora, G. Oristrell, and J. Tabernero

Bone Marrow Toxicity: Red Blood Cells

Pere Gascon

Bone Marrow Toxicity: White Blood Cells

Matti S. Aapro

Toxicity of Bone-Targeted Agents in Malignancy

Caroline Wilson, Fiona Taylor, and Robert Coleman

State of the Art of Antiemetic Therapy

Sonia Fatigoni and Fausto Roila

Side Effects of Nociceptive Cancer Pain Treatments in Adults

Ivan Krakowski and Aline Henry

Totally Implanted Access Ports: Indications and Prevention of Complications

Didier S. Kamioner

Mario Dicato, Hematology-Oncology Service at Luxembourg Medical Center, Luxembourg, and Head of the Research Laboratory of the Luxembourg Foundation for Research on Cancer and Blood Disorders. M. Dicato trained at Lausanne University, completed his postgraduate training at the Universities of Geneva, Switzerland, Pittsburgh and Yale, USA. He did his fellowship (subspecialty training) in hematology at the Massachusetts General Hospital, Boston and was Clinical and Research Fellow in Medicine at Harvard University, Boston, USA.He has published more than 250 papers and numerous book chapters, and is an editorial board member of several scientific journals.

Eric VanCutsem, MD, PhD, is professor at the University of Leuven and  head of the division of Digestive Oncology at the University Hospitals Leuven, Belgium. He trained at the University of Leuven and spent part of his training in Lausanne, Bristol, San Antonio and Rotterdam. He published more than 500 peer-reviewed articles. He is member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation Against. He is/was a committee or board member of several international scientific organizations, including ESMO, ASCO, EORTC, UEG, ESDO, ENETS. 

Updated to reflect latest progress made in drug discovery, including immunotherapy drugs

A consistency of format from chapter to chapter to facilitate easy look-up

Provides methods of prevention and/or treatment for the various side effects of a comprehensive sweep of systemic treatments

Date de parution :

Ouvrage de 513 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

137,14 €

Ajouter au panier